Literature DB >> 10795883

Molecular factors underlying selective vulnerability of motor neurons to neurodegeneration in amyotrophic lateral sclerosis.

P J Shaw1, C J Eggett.   

Abstract

Current research evidence suggests that genetic factors, oxidative stress and glutamatergic toxicity, with damage to critical target proteins and organelles, may be important contributory factors to motor neuron injury in amyotrophic lateral sclerosis (ALS). Various molecular and neurochemical features of human motor neurons may render this cell group differentially vulnerable to such insults. Motor neurons are large cells with long axonal processes which lead to requirements for a high level of mitochondrial activity and a high neurofilament content compared to other neuronal groups. The lack of calcium buffering proteins parvalbumin and calbindin D28k and the low expression of the GluR2 AMPA receptor subunit may render human motor neurons particularly vulnerable to calcium toxicity following glutamate receptor activation. Motor neurons also have a high perisomatic expression of the glutamate transporter protein EAAT2 and a very high expression of the cytosolic free radical scavenging enzyme Cu/Zn superoxide dismutase (SOD1) which may render this cell group vulnerable in the face of genetic or post-translational alterations interfering with the function of these proteins. More detailed characterisation of the molecular features of human motor neurons in the future may allow the strategic development of better neuroprotective therapies for the benefit of patients afflicted by ALS.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10795883     DOI: 10.1007/bf03161151

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  94 in total

Review 1.  Glutamate receptor channels: novel properties and new clones.

Authors:  B Sommer; P H Seeburg
Journal:  Trends Pharmacol Sci       Date:  1992-07       Impact factor: 14.819

Review 2.  Role of Ca2+ in toxic cell killing.

Authors:  S Orrenius; D J McConkey; G Bellomo; P Nicotera
Journal:  Trends Pharmacol Sci       Date:  1989-07       Impact factor: 14.819

3.  Glutamate uptake is decreased tardively in the spinal cord of FALS mice.

Authors:  T Canton; J Pratt; J M Stutzmann; A Imperato; A Boireau
Journal:  Neuroreport       Date:  1998-03-30       Impact factor: 1.837

4.  Selective loss of glial glutamate transporter GLT-1 in amyotrophic lateral sclerosis.

Authors:  J D Rothstein; M Van Kammen; A I Levey; L J Martin; R W Kuncl
Journal:  Ann Neurol       Date:  1995-07       Impact factor: 10.422

5.  Increased expression of neurofilament subunit NF-L produces morphological alterations that resemble the pathology of human motor neuron disease.

Authors:  Z Xu; L C Cork; J W Griffin; D W Cleveland
Journal:  Cell       Date:  1993-04-09       Impact factor: 41.582

6.  Amyotrophic lateral sclerosis and structural defects in Cu,Zn superoxide dismutase.

Authors:  H X Deng; A Hentati; J A Tainer; Z Iqbal; A Cayabyab; W Y Hung; E D Getzoff; P Hu; B Herzfeldt; R P Roos
Journal:  Science       Date:  1993-08-20       Impact factor: 47.728

7.  Light and electron microscopic distribution of the AMPA receptor subunit, GluR2, in the spinal cord of control and G86R mutant superoxide dismutase transgenic mice.

Authors:  B M Morrison; W G Janssen; J W Gordon; J H Morrison
Journal:  J Comp Neurol       Date:  1998-06-15       Impact factor: 3.215

8.  Intracellular calcium parallels motoneuron degeneration in SOD-1 mutant mice.

Authors:  L Siklós; J I Engelhardt; M E Alexianu; M E Gurney; T Siddique; S H Appel
Journal:  J Neuropathol Exp Neurol       Date:  1998-06       Impact factor: 3.685

9.  Transgenic mice carrying a human mutant superoxide dismutase transgene develop neuronal cytoskeletal pathology resembling human amyotrophic lateral sclerosis lesions.

Authors:  P H Tu; P Raju; K A Robinson; M E Gurney; J Q Trojanowski; V M Lee
Journal:  Proc Natl Acad Sci U S A       Date:  1996-04-02       Impact factor: 11.205

10.  Protective effect of riluzole on excitatory amino acid-mediated neurotoxicity in motoneuron-enriched cultures.

Authors:  A G Estevez; J M Stutzmann; L Barbeito
Journal:  Eur J Pharmacol       Date:  1995-06-23       Impact factor: 4.432

View more
  51 in total

Review 1.  Motor neurone disease.

Authors:  P J Shaw
Journal:  BMJ       Date:  1999-04-24

2.  Regulation of glutamate transporters in astrocytes: evidence for a relationship between transporter expression and astrocytic phenotype.

Authors:  Chrissandra J Zagami; Ross D O'Shea; Chew L Lau; Surindar S Cheema; Philip M Beart
Journal:  Neurotox Res       Date:  2005       Impact factor: 3.911

3.  Linking selective vulnerability to cell death mechanisms in Parkinson's disease.

Authors:  Dennis W Dickson
Journal:  Am J Pathol       Date:  2007-01       Impact factor: 4.307

Review 4.  MR imaging findings in hepatic encephalopathy.

Authors:  A Rovira; J Alonso; J Córdoba
Journal:  AJNR Am J Neuroradiol       Date:  2008-06-26       Impact factor: 3.825

5.  Optimized methods for rapidly dissecting spinal cords and harvesting spinal motor neurons with high survival and purity from rats at different embryonic stages.

Authors:  Shudong Chen; Ruimin Tian; Hui Li; Meihui Chen; Hu Zhang; Dingkun Lin
Journal:  J Spinal Cord Med       Date:  2017-05-25       Impact factor: 1.985

Review 6.  Spreading of pathology in neurodegenerative diseases: a focus on human studies.

Authors:  Johannes Brettschneider; Kelly Del Tredici; Virginia M-Y Lee; John Q Trojanowski
Journal:  Nat Rev Neurosci       Date:  2015-01-15       Impact factor: 34.870

7.  DREAM-Dependent Activation of Astrocytes in Amyotrophic Lateral Sclerosis.

Authors:  Pilar Larrodé; Ana Cristina Calvo; Laura Moreno-Martínez; Miriam de la Torre; Leticia Moreno-García; Nora Molina; Tomás Castiella; Cristina Iñiguez; Luis Fernando Pascual; Francisco Javier Miana Mena; Pilar Zaragoza; Santiago Ramón Y Cajal; Rosario Osta
Journal:  Mol Neurobiol       Date:  2018-01       Impact factor: 5.590

Review 8.  Molecular pathways of motor neuron injury in amyotrophic lateral sclerosis.

Authors:  Laura Ferraiuolo; Janine Kirby; Andrew J Grierson; Michael Sendtner; Pamela J Shaw
Journal:  Nat Rev Neurol       Date:  2011-11       Impact factor: 42.937

Review 9.  Cross talk between SOD1 and the mitochondrial UPR in cancer and neurodegeneration.

Authors:  Maria Gomez; Doris Germain
Journal:  Mol Cell Neurosci       Date:  2019-04-24       Impact factor: 4.314

10.  Selective neuronal vulnerability to oxidative stress in the brain.

Authors:  Xinkun Wang; Elias K Michaelis
Journal:  Front Aging Neurosci       Date:  2010-03-30       Impact factor: 5.750

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.